Biotech News

Scholar Rock to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026

Scholar Rock (SRRK)Scholar Rock2026-06-25 13:46 ESTEarnings

CAMBRIDGE, Mass. --(BUSINESS WIRE)--Feb. 10, 2026-- Scholar Rock (NASDAQ: SRRK) today announced that it will report fourth quarter and full year 2025 financial results on Tuesday, March 3, 2026, before the financial markets open. The Company will host a conference call and webcast with Scholar Rock

Open original release

Related news

SRRKScholar Rock2026-06-25 13:46 EST

Scholar Rock to Showcase Neuromuscular Research Portfolio at 2026 Annual Cure SMA Research and Clinical Care Meeting and 2026 International Research Congress on FSHD

SRRKScholar Rock2026-06-25 13:46 EST

Scholar Rock to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

SRRKScholar Rock2026-06-25 13:46 EST

Scholar Rock to Present at the 2026 Jefferies Global Healthcare Conference

SRRKScholar Rock2026-06-25 13:46 EST

Scholar Rock Reports First Quarter 2026 Financial Results and Recent Business Highlights

SRRKScholar Rock2026-06-25 13:46 EST

Scholar Rock to Present at Upcoming Investor Conferences

SRRKScholar Rock2026-06-25 13:46 EST

Scholar Rock Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

SRRKScholar Rock2026-06-25 13:46 EST

CORRECTING and REPLACING Scholar Rock Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

SRRKScholar Rock2026-06-25 13:46 EST

Scholar Rock Resubmits Biologics License Application (BLA) to FDA for Apitegromab for Treatment of Children and Adults with Spinal Muscular Atrophy (SMA)

SRRKScholar Rock2026-06-25 13:46 EST

Scholar Rock to Report First Quarter 2026 Financial Results on May 7, 2026

SRRKScholar Rock2026-06-25 13:46 EST

Scholar Rock to Present at the BofA Securities 2026 Health Care Conference

View all latest news

Scholar Rock

Scholar Rock is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

SRRKScholar Rock2026-06-26 10:03 EST

Scholar Rock to Showcase Neuromuscular Research Portfolio at 2026 Annual Cure SMA Research and Clinical Care Meeting and 2026 International Research Congress on FSHD

SRRKScholar Rock2026-06-26 10:03 EST

Scholar Rock to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

SRRKScholar Rock2026-06-26 10:03 EST

Scholar Rock to Present at the 2026 Jefferies Global Healthcare Conference

SRRKScholar Rock2026-06-26 10:03 EST

Scholar Rock Reports First Quarter 2026 Financial Results and Recent Business Highlights

SRRKScholar Rock2026-06-26 10:03 EST

Scholar Rock to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026

Stock data

Close: —
Market cap: —
Exchange: NASDAQ
Sector: Biotechnology
Location: United States